Yue Xiang

Chongqing University of Science and Technology

Also affiliated with China University of Mining and Technology

EngineeringPharmacology, Toxicology and PharmaceuticsMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “FDA Approval Summary: Tremelimumab in Combination with Durvalumab for the Treatment of Patients with Unresectable Hepatocellular Carcinoma”.

FDA Approval Summary: Tremelimumab in Combination with Durvalumab for the Treatment of Patients with Unresectable Hepatocellular Carcinoma

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-2124

N/A

1.4DataRank · unranked

64 citations

Jamie R. Brewer, Jiaxin Fan, Joyce Cheng, Yuan Li Shen, Yue Xiang +6 more

Effects of Single Dose Rifampin on the Pharmacokinetics of Fluvastatin in Healthy Volunteers

Clinical Pharmacology & Therapeutics(2021)10.1002/cpt.2268

N/A

0DataRank · unranked

5 citations

Hideaki Okochi, Ivan Kozachenko, Jasleen K. Sodhi, Lynda Frassetto, Leslie Z. Benet +1 more

Application of Kirchhoff’s Laws to pharmacologic and pharmacokinetic analyses

Pharmacological Reviews(2025)10.1016/j.pharmr.2025.100050

N/A

0DataRank · unranked

6 citations

Jasleen K. Sodhi, Markus Ville Tiitto, Yue Xiang, Leslie Z. Benet